Porton Reports Strong Half-Year Results
…
2021 Pharmaceutical Crystallization Summit Program Announced by CfPC
The Center for Pharma Crystallization (CfPC) at J-STAR Research, Inc., a US based subsidiary of Porton Pharma Solutions, is pleased to announce the program of the 2nd annual Pharmaceutical Crystallization Summit, to be held on October 14 and 15, 2021, …
J-STAR Research, Inc launches new website
South Plainfield, NJ., March 12, 2020 — J-STAR Research, Inc, the leading Contract Research Organization focused on Small Molecule Process Research and Crystallization R&D, is proud to announce the launch of its newly redesigned website at https://jstar-bkp.sytech.site. The new site …
Porton and Xtalpi Announced Strategic Cooperation
March 10, 2020, Chongqing • China–XtalPi Inc.(hereafter referred to as XtalPi), an algorithm-driven AI pharmaceutical technology company, announced the signing of a strategic cooperation agreement today. The two parties aim to carry out all-round strategic cooperation on the …
Porton Completes Acquisition of Porton USA
CRANBURY, N.J., Wednesday April 5th, 2017—Porton Fine Chemicals, Ltd., (“Porton”, SZ 300363), a China-based contract development and manufacturing organization （CDMO） serving the global pharmaceutical industry, today announced that Porton USA, L.L.C. (“PTC”), a wholly-owned subsidiary of Porton, has closed the …
Porton Completes Acquisition of J-STAR Research
CRANBURY, N.J., Wednesday April 5th, 2017—Porton Fine Chemicals, Ltd., (“Porton”, SZ 300363), a China-based contract development and manufacturing organization （CDMO） serving the global pharmaceutical industry, today announced that Porton USA, L.L.C. (“PTC”), a wholly-owned subsidiary of Porton, has closed the …
Porton USA Acquires J-STAR Research to Enhance R&D Capabilities
CRANBURY, N.J., Jan. 27, 2017 /PRNewswire/ — Porton Fine Chemicals, Ltd., (“Porton”, SZ 300363), a China-based contract development and manufacturing organization (CDMO) serving the global pharmaceutical industry, today announced that Porton USA, L.L.C. (“PTC”), a wholly-owned subsidiary …
Porton USA Acquires J-STAR Research to Enhance R&D Capabilities
CRANBURY, N.J., Jan. 27, 2017 /PRNewswire/ — Porton Fine Chemicals, Ltd., (“Porton”, SZ 300363), a China-based contract development and manufacturing organization (CDMO) serving the global pharmaceutical industry, today announced that Porton USA, L.L.C. (“PTC”), a wholly-owned subsidiary …